Deven Choksey recommended accumulate rating on Acutaas Chemicals with a target price of Rs 1783 in its research report dated October 27, 2025.
KR Choksey is bullish on Ami Organics has recommended buy rating on the stock with a target price of Rs 2613 in its research report dated January 29, 2025.
KR Choksey recommended accumulate rating on Ami Organics with a target price of Rs 1994 in its research report dated October 30, 2024.
KR Choksey recommended accumulate rating on Ami Organics with a target price of Rs 1374 in its research report dated August 21, 2024.
KR Choksey recommended accumulate rating on Ami Organics with a target price of Rs 1200 in its research report dated February 19, 2024.
The return of the flu season in India and the US, and COVID-19 in China sparked more investor interest in the sector.
KR Choksey is bullish on Ami Organicss has recommended buy rating on the stock with a target price of Rs 1229 in its research report dated August 12, 2022.
Hem Securities is bullish on Ami Organics has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated June 02, 2022.
The Ankleshwar facility expansion would enhance the capacity of pharma inter-mediates by 2.8 times. This would take care of the anticipated demand till FY27
Overall valuations, seen in the context of high growth and elevated margins, make Ami Organics a stock worth looking at
One of the key strengths of Ami Organics, in our opinion, is its expertise in Piperazine chemistry
KR Choksey is bullish on Ami Organics has recommended buy rating on the stock with a target price of Rs 1229 in its research report dated January 06, 2022.
Anand Rathi is bullish on Ami Organics has recommended buy rating on the stock with a target price of Rs 1354 in its research report dated December 29, 2021.
According to the management of Ami Organics, the priority for the acquired business of Gujarat Organics is to stabilise revenue and focus on reducing inefficiencies
Post the strong listing, multiples are close to some of the larger players in chemicals, having their end-market as pharma.
Intermediates are the key area where import dependence is huge, and, hence, a company like Ami Organics is likely to benefit